losartan has been researched along with bq 610 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Minnich, LA; Nowicki, PT | 1 |
| Asico, LD; Bek, M; Eisner, GM; Goldstein, DS; Grandy, DK; Jose, PA; Li, XX; Rubinstein, M; Yang, Z | 1 |
2 other study(ies) available for losartan and bq 610
| Article | Year |
|---|---|
Effects of systemic hypotension on postnatal intestinal circulation: role of angiotensin.
Topics: Aging; Angiotensin II; Animals; Animals, Newborn; Hemodynamics; Hypotension; In Vitro Techniques; Intestinal Mucosa; Intestines; Losartan; Oligopeptides; Oxygen Consumption; Regional Blood Flow; Swine; Vascular Resistance; Vasoconstriction | 1999 |
Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice.
Topics: Adrenergic alpha-Antagonists; Angiotensin Receptor Antagonists; Animals; Antidiuretic Hormone Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Body Weight; Catechols; Endothelin Receptor Antagonists; Endothelin-1; Female; Genotype; Hypertension; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Oligopeptides; Phentolamine; Piperidines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Adrenergic; Receptors, Dopamine D2; Receptors, Endothelin; Sodium; Sodium-Potassium-Exchanging ATPase; Urodynamics; Viper Venoms | 2001 |